Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Tags Metabolism
ANGPTL
(6)
ATP Citrate Lyase
(17)
Acetyl-CoA Carboxylase
(46)
Aconitase
(2)
Acyltransferase
(171)
Adenosine Deaminase
(23)
AhR
(32)
Amino Acids and Derivatives
(1134)
Aminopeptidase
(96)
Amylase
(71)
Angiotensin-converting Enzyme (ACE)
(207)
Apolipoprotein
(9)
CETP
(23)
CPT
(5)
Calcium Channel
(841)
Carbonic Anhydrase
(274)
Casein Kinase
(185)
Cytochromes P450
(690)
DHFR
(80)
Decarboxylase
(7)
Dehydrogenase
(577)
Drug Metabolite
(905)
Endogenous Metabolite
(4416)
Enteropeptidase (EP)
(6)
Epoxide Hydrolase
(68)
FAAH
(77)
FABP
(20)
FMO
(1)
FXR
(95)
Factor VIII
(8)
Factor VIIa
(7)
Factor Xa
(114)
Fatty Acid Synthase
(85)
GHR
(4)
GSNOR
(5)
Glucokinase
(76)
Glucosidase
(219)
Glutathione Peroxidase
(110)
Glyoxalase
(18)
HIF/HIF Prolyl-Hydroxylase
(242)
HMG-CoA Reductase
(97)
HSP
(324)
Hexokinase
(12)
Hydrogenase
(2)
Hydroxylase
(51)
IDO
(108)
Indoleamine 2,3-Dioxygenase (IDO)
(110)
Isocitrate Dehydrogenase (IDH)
(53)
LDL
(26)
LDLR
(52)
Lipase
(91)
Lipid
(68)
Liposome
(643)
Lipoxygenase
(249)
Liver X Receptor
(62)
MAGL
(70)
MAO
(110)
MTP
(12)
Mitochondrial Metabolism
(313)
N-Acetylglucosaminyltransferase
(1)
NADPH
(85)
NAMPT
(59)
NEDD4-1
(3)
NEDD8
(9)
NUDIX hydrolase
(2)
Neprilysin
(46)
PAI-1
(51)
PDE
(663)
PGK1
(3)
PKM
(57)
PPAR
(501)
Phosphatase
(589)
Phospholipase
(245)
Phosphorylase
(29)
Photosystem (PS)
(8)
Procollagen C Proteinase
(2)
Prolyl Endopeptidase (PREP)
(39)
RAR/RXR
(12)
REV-ERB
(11)
ROR
(109)
Reactive Oxygen Species
(922)
Reductase
(194)
Retinoid Receptor
(126)
SGK
(27)
Serine/threonin kinase
(111)
Stearoyl-CoA Desaturase (SCD)
(39)
Sulfotransferase
(1)
Taste receptor
(16)
Thioredoxin
(2)
Transaminase
(3)
Transferase
(282)
Transketolase
(14)
UGT
(22)
Vitamin
(104)
Xanthine Oxidase
(99)
glycosidase
(326)
hCE
(2)
stilbene oxidase
(1)
transporter
(120)

GSNOR

S-Nitrosoglutathione (GSNO) is an endogenous S-nitrosothiol (SNO) that plays a critical role in nitric oxide (NO) signaling and is a source of bioavailable NO. NO coexists in cells with SNOs that serve as endogenous NO carriers and donors. SNOs spontaneously release NO at different rates and can be powerful terminators of free radical chain propagation reactions, by reacting directly with ROO• radicals, yielding nitro derivatives as end products. NO is generated intracellularly by the nitric oxide synthase (NOS) family of enzymes: nNOS, eNOS and iNOS while the in vivo source of many of the SNOs is unknown. In oxygenated buffers, however, formation of SNOs is due to oxidation of NO to dinitrogen trioxide (N2O3). Some evidence suggests that both exogenous NO and endogenously derived NO from nitric oxide synthases can react with glutathione to form GSNO.

N6022
T69011208315-24-5
N6022(IC50 of 8 nM) is an effective, reversible, and selective S-Nitrosoglutathione reductase(GSNOR) inhibitor.
  • $40
In Stock
Size
QTY
TargetMol | Citations Cited
Cavosonstat
N-91115, N91115, N 91115
T269551371587-51-7In house
Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor that promotes cystic fibrosis transmembrane conductance regulator (CFTR) maturation and plasma membrane stabilization. As a CFTR stabilizer, Cavosonstat can be used to study cystic fibrosis.
  • $39
In Stock
Size
QTY
SPL-334
SPL334
T28837688347-51-5
SPL-334 is an inhibitor of S-nitrosoglutathione reductase.
  • $193
3-6 months
Size
QTY
GSNOR-IN-1
T212135
GSNOR-IN-1 is a prodrug of GSNOR-IN-2 and functions as an S-nitrosoglutathione reductase (GSNOR) inhibitor capable of crossing the blood-brain barrier. GSNOR-IN-1 offers significant protective effects against damage induced by oxygen-glucose deprivation/reoxygenation (OGD/R). It regulates calcium signaling and synaptic function through Clstn1 S-nitrosylation and inhibits neuronal apoptosis. Additionally, GSNOR-IN-1 markedly reduces infarct volume in rat models of ischemic stroke while enhancing neurological function. With its neuroprotective properties, GSNOR-IN-1 holds potential for ischemic stroke research.
  • Inquiry Price
Inquiry
Size
QTY
GSNOR-IN-2
T211791
GSNOR-IN-2 (Compound 45) is an inhibitor of S-nitrosoglutathione reductase (GSNOR) with an IC50 of 44.12 nM. It exhibits neuroprotective properties and shows potential for research in ischemic stroke.
  • Inquiry Price
Inquiry
Size
QTY